Skip to main content
. 2020 Oct 27;10(4):1751–1761. doi: 10.3233/JPD-202058

Fig. 5.

Fig. 5

Change from baseline to week 8 in (A) SCOPA-GS, (B) SCOPA-NS, and (C) SCOPA-DS in all patients included in efficacy analyses. BL, baseline; LS, least squares; SCOPA-DS, Scale for Outcomes in Parkinson’s Disease–daytime sleepiness; SCOPA-GS, Scale for Outcomes in Parkinson’s Disease–global sleep; SCOPA-NS, Scale for Outcomes in Parkinson’s Disease–nighttime sleep; SE, standard error.